Filing Flows › Anika Therapeutics (ANIK) › How it makes money
How Anika Therapeutics (ANIK) makes money
Anika Therapeutics (ANIK) made $30.6M of revenue in the third quarter 2026 (Q3 2026), +10% from a year earlier. OEM Channel brought in $16.6M (54%); Commercial Channel brought in $14.0M (46%).
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| OEM Channel | $16.6M | 54.3% | -11% | +5% |
| Commercial Channel | $14.0M | 45.7% | +0.6% | +17% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $30.6M | 100.0% |
| Operating cash flow | $8.4M | 27.4% |
| Free cash flow | $6.7M | 22.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $30.6M | +10% |
| Q2 2026 | $32.6M | +16% |
| Q1 2026 | $29.6M | +13% |
| Q4 2025 | $30.6M | 0% |
| Q3 2025 | $27.8M | -6% |
| Q2 2025 | $28.2M | -8% |
| Q1 2025 | $26.2M | -10% |
From Anika Therapeutics' 10-Q filed Nov 6, 2026 (on EDGAR).
Questions
How does Anika Therapeutics make money?
Anika Therapeutics (ANIK) made $30.6M of revenue in the third quarter 2026 (Q3 2026), +10% from a year earlier. OEM Channel brought in $16.6M (54%); Commercial Channel brought in $14.0M (46%).
What is Anika Therapeutics' biggest business?
OEM Channel: $16.6M in the third quarter 2026, 54% of revenue, +5% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.